Watches a blood-filtering device in adults with AIDS and serious lung or blood infections
Studies a blood-filtering device in adults with AIDS and severe infections.
Plain-language title generated from the registry record
Registry title: Clinical Application of Cytokine Adsorption Technique in AIDS Patients With Severe Pneumonia and/or Septic Shock
Key facts
- Where
- Guangzhou, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT06145828, who can take part
Where in China
- Guangzhou Eighth People's Hospital, Guangzhou Medical UniversityGuangzhou, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Guangzhou 8th People's Hospital
- Trial code
- NCT06145828
- Record updated
- 24 November 2023
- Original description
Observing the Real-World Application Effectiveness of Cytokine Immune Adsorption Technology in AIDS Patients with Severe Pneumonia or septic shock.Read full original descriptionShow less
Clinical Application of Cytokine Adsorption Technology in AIDS Patients With Severe Pneumonia and/or Septic Shock: An Observational Study.
Observing the Real-World Application Effectiveness of Cytokine Immune Adsorption Technology in AIDS Patients with Severe Pneumonia or septic shock.
Inclusion: Confirmed HIV infection; Progression to AIDS stage: CD4+ count <200 cells/ul and/or occurrence of AIDS opportunistic infections; Age between 18 and 65 years; Meeting the diagnosis of severe pneumonia or septic shock:; The criteria for severe pneumonia diagnosis refer to the 2021 ATS (American Thoracic Society) and IDSA (Infectious Diseases Society of America) guidelines for the treatment of community-acquired pneumonia; The criteria for septic shock refer to the Chinese Society of Critical Care Medicine's "Chinese Guidelines for the Emergency Treatment of Sepsis/Septic Shock (2018).
Exclusion: Concurrent AIDS-related or unrelated tumors; Alcohol abuse or drug use; Coexisting central nervous system lesions, severe liver disease, or cirrhosis; Severe underlying diseases of the heart, lungs, liver, kidneys, etc; The researcher believes that the overall condition of the subject affects the evaluation and completion of the trial; Women who are pregnant or breastfeeding.